BESignificantSSM supervised
Crelan
549300DYPOFMXOR7XM56Resolution authority: Single Resolution Board
CET1 ratio
22.3%
Total capital ratio
28.92%
Leverage ratio
4.79%
MREL requirement
Not disclosedMREL resources
50.18%
Internal MREL
Not disclosedLiquidity coverage ratio
185.99%
Net stable funding ratio
130.8%
Capital-stack instruments
| ISIN | Instrument | Seniority | Coupon | Maturity▴ | Amount |
|---|---|---|---|---|---|
| BE0002913946 | Crelan S.A. EO-Non-Pref. Med.-T.Nts 23(28) | SP | 5.75% | 2028-01-26 | EUR 500m |
| BE0002936178 | CRELAN6%28FEB2030 | SP | 6% | 2030-02-28 | EUR 600m |
| BE0002989706 | CRELAN5.25%23JAN32 | SP | 5.25% | 2032-01-23 | EUR 750m |
| BE0390130939 | CRELA5.375%30APR35 | AT1 | 5.375% | 2035-04-30 | EUR 300m |
| BE0390249184 | Crelan FX 3.875% SEP36 CALL EUR | SP | 3.875% | 2036-09-15 | EUR 500m |
| BE0390287564 | Crelan SA NV 4% 30 04 2037 | T2 | 4% | 2037-04-30 | EUR 300m |
BE0002913946Crelan S.A. EO-Non-Pref. Med.-T.Nts 23(28)
BE0002936178CRELAN6%28FEB2030
BE0002989706CRELAN5.25%23JAN32
BE0390130939CRELA5.375%30APR35
BE0390249184Crelan FX 3.875% SEP36 CALL EUR
BE0390287564Crelan SA NV 4% 30 04 2037